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Abstract: Protease activities in allergen sources are thought to be
involved in triggering allergic inflammation through the disruption
of epithelial barrier or the induction of proinflammatory cytokines.
Protease allergens may also work as type 2 helper T cell (TH2)
adjuvants through the cleavage of cell surface receptors. Here, we
report molecular cloning and immunochemical characterization of a
new Japanese cedar (Cryptomeria japonica) pollen allergen (CPA9)
homologous to serine protease, which is initially found as a high
IgE-binding spot on our two-dimensional (2-D) IgE immunoblotting
map. The cpa9 cDNA encoded a 757 amino acid polypeptide
showing a significant sequence identity with plant subtilisin-like
serine protease family members including melon major allergen Cuc
m 1. We found that native CPA9 purified from C. japonica pollen
showed a high IgE-binding frequency and IgE cross-reactivity with
melon extract.
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Japanese cedar (Cryptomeria japonica) pollinosis is one ofthe most serious allergic diseases in Japan,1 and elucidation
of its major allergen repertoire is critical for the development
of component-resolved diagnosis and specific immunother-
apy. Previous studies have exclusively been focused on the 2
major allergens Cry j 12,3 and Cry j 2,4,5 but the other allergen
molecules have yet to be characterized thus far. Our group
has reported the existence of 131 C. japonica pollen allergen
spots on the 2-D IgE immunoblotting map, in which 31 spots
shows higher IgE-binding frequency than that of Cry j 2.6 We
also have identified additional new C. japonica pollen aller-
gen molecules structurally belonging to isoflavone reductase
(IFR)7, class IV chitinase,8 and nonspecific lipid transfer
protein (LTP).9 The IFR allergen (CJP-6) is homologous to
birch pollen allergen Bet v 510 and pear allergen Pyr c 5
(GenBank Accession No. AF071477), and shows 76% (19/
25) IgE-binding frequency.7 The chitinase allergen (CJP-4) is
a potent major allergen with 100% (31/31) IgE-binding fre-
quency and IgE-cross-reactivity with latex C serum.8 The
LTP allergen (CJP-8) also cross-reacts with other LTP aller-
gens from peach (Pru p 3) and Parietaria judaica pollen (Par
j 1).9 Fujimura et al have recently reported a taumatin-like C.
japonica pollen allergen Cry j 311 with low IgE-binding
capacity (27%, 27/100).
Many aeroallergens have been shown to possess pro-
teolytic activity. The best-characterized protease allergen is
the cysteine protease antigens Der f 1 and Der p 1 from the
house dust mite (Dermatophagoides farinae and D. pteron-
yssinus). Proteolytic activity of those allergens may trigger
proallergic inflammation through the proteolytic degradation
of epithelial tight junctions,12 the release of proinflammatory
cytokines from mucosal epithelial cells,13 or augmentation of
IgE synthesis.14–16 These cysteine protease allergens may act
as a TH2 adjuvant through proteolytic cleavage of CD25 on T
cells17 or in concert with basophils.18 Serine proteases repre-
sent additional major aeroallergens. The house dust mite
contains 3 classes of serine proteases designated as the group
3 (trypsin), the group 6 (chymotrypsin), and the group 9
(collagenase)19 allergens. Sun et al have shown that both Der
p 3 and Der p 9 from D. pteronyssinus trigger the release of
GM-CSF and eotaxin from human lung epithelial cells.20
Indoor airborne allergenic fungi Penicillium species also
contain the group 13 (alkaline serine protease) and the group
18 (vacuolar serine protease) family members,21 and the P.
chrysogenum Pen ch 13 allergen induces proinflammatory
mediator releasing and degradation of a tight junction protein
(occludin) in lung epithelial cells.22 Allergenic pollen grains
also contain a significant amount of proteases,23 and indeed
we have recently identified the first major C. japonica pollen
allergen (CPA63) homologous to the plant atypical aspartic
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protease/nucleoid DNA-binding protein family members.24 In
this study, we describe cDNA cloning and immunochemical
characterization of a new subtilisin-like serine protease aller-
gen (CPA9), which has originally been found as a major
allergen spot with a high IgE-binding frequency (50%, 20/40)
on our 2-D IgE immunoblotting map.6
MATERIALS AND METHODS
Human Sera
Sera from C. japonica pollen-allergic patients were
obtained from 26 donors selected on the basis of clinical
history and positive IgE-binding to C. japonica pollen (RAST
score 2). Nonallergic sera from 5 healthy volunteers were
used as a negative control. These sera were stored at 30°C
until use. All experiments were approved by the Institutional
Review Board of Takanobashi Central Hospital and were
described in detail to all participants before they provided
their informed consent and were admitted into the study.
Time-of-Flight Mass Spectrometry (TOF-MS)
Our previous 2-D IgE immunoblotting study of C.
japonica pollen6 revealed that the allergen spot No. 9 (CPA9)
was one of unidentified major allergens with high IgE-
binding frequency (50%, 20/40). To obtain its partial amino
acid sequence information, the CPA9 spot was excised from
the 2-D SDS-PAGE gel, and subjected to tryptic in-gel
digestion as described.6 The MALDI-TOF-MS and tandem
MS/MS analyses were then performed using an Ultraflex
TOF/TOF spectrometer (Bruker Daltonics, Billerica, MA).
The obtained MS and MS/MS spectra were submitted to
Mascot database (Matrix Science, London, UK) for homol-
ogy search. De novo peptide sequencing was carried out
using BioTools software (Bruker Daltonics) and derived
sequences were also subjected to Mascot (Matrix Science) for
assignment of protein identity.
cDNA Cloning
The extraction of C. japonica pollen RNA and cDNA
cloning were performed as previously descried.24 In brief,
total RNA was extracted from frozen C. japonica anther (5 g,
crashed in liquid nitrogen) using Concert Plant RNA Reagent
(Invitrogen, Carlsbad, CA), and mRNA was selected by
Oligotex-dT30 Super mRNA Purification Kit (Takara Bio,
Otsu, Japan). cDNA templates for Rapid Amplification of
cDNA Ends (RACE)-PCR were synthesized using BD
SMART RACE cDNA Amplification Kit (BD Biosciences,
San Jose, CA). 5- and 3-RACE PCR were then carried out
using BD Advantage 2 PCR Kit (BD Biosciences) with cpa9
gene-specific primers (sequence information will be appeared
elsewhere). Resulting PCR fragments were subcloned into
pGEM-T Easy (Promega, Madison, WI), and both strands of
the nucleotide sequences were determined using ABI PRISM
3100 Avant Genetic Analyzer (Applied Biosystems, Foster
City, CA).
Preparation of Recombinant CPA9 (r-CPA9)
and Its Specific Antisera
Expression system of r-CPA9 was developed using Esch-
erichia coli cold shock expression vector pCold-TF DNA
(Takara Bio) as described.9 Briefly, the full-length cpa9 cDNA
was inserted into pCold-TF, and E. coli Rosetta gami was
transformed with the resultant expression construct. Expression
of trigger factor (TF)-tagged r-CPA9 (r-TF-CPA9) was induced
upon cultivation of the transformant at 15°C, and the recombi-
nant protein was then semi-purified on a HisTrap HP metal
chelate affinity column (GE Healthcare Bio-Sciences, Uppsala,
Sweden). The purified protein was then digested with thrombin
(Novagen, Madison, WI) to remove TF-tag, and r-CPA9 was
finally purified by SDS-PAGE and gel-extraction procedures as
described.9 To obtain CPA9-specific antisera, BALB/c mice (4
weeks of age, Charles River Japan, Yokohama) were immu-
nized intraperitoneally with purified r-CPA9 using Titer-Max
Gold adjuvant (CytRx Corporation, Norcross, GA) every 2
weeks for 8 weeks. The antisera were collected 10 days after the
final immunization.
SDS-PAGE and Immunoblotting
Protein samples were analyzed by SDS-PAGE on a
12.5% slab gel, and protein bands were detected by silver
staining. For immunoblotting analysis of CPA9, protein samples
were electronically transferred onto a polyvinylidene difluoride
(PVDF) membrane (Immobilon-P, Millipore, Bedford, MA).
After blocking with phosphate-buffered saline (PBS) supple-
mented with 0.05% Tween 20 and 5% skim milk, the blot was
probed with anti-CPA9 sera (1:5,000 in the blocking buffer).
After washing, the blot was reacted with secondary horseradish
peroxidase-conjugated rabbit antimouse IgG polyclonal anti-
body (Sigma, St. Louis, MO). The protein bands were visualized
on an x-ray film (Konica Minolta, Tokyo, Japan) using an ECL
Plus Western Blotting Detection Kit (GE Healthcare Bio-Sci-
ences). To detect His-tagged r-CPA9, the immunoblotting pro-
cedure with anti-His tag monoclonal antibody (GE Healthcare
Bio-Sciences) was carried out as described.9
Purification of Native CPA9 (n-CPA9)
Crude C. japonica pollen extract was prepared as de-
scribed.7 The extract (50 g) was then dissolved in 1.5 M
(NH4)2SO4/20 mM Tris-HCl (pH 8.6), and applied onto a
HiTrap Butyl HP hydrophobic interaction column (GE Health-
care Bio-Sciences). The proteins were fractionated by decreas-
ing the (NH4)2SO4 concentration. The active fractions contain-
ing n-CPA9 (assessed by anti-CPA9 immunoblotting) were
concentrated/desalted, and then applied onto a Mono Q anion
exchange column (GE Healthcare Bio-Sciences) to obtain n-
CPA9. Identity of n-CPA9 sample was verified by the MALDI-
TOF-MS and tandem MS/MS sequencing analyses as described
above.
Enzyme-Linked Immunosorbent Assay (ELISA)
and Competitive ELISA
ELISA was used to evaluate the IgE-binding frequency of
n-CPA9 as essentially described7 with minor modifications. In
brief, a 96-well Microtiter plate (NUNC-Immuno Plate Maxi-
sorp F96, Nalge Nunc International, Roskilde, Denmark) was
coated with 50 L of antigen solution (500 ng/ml in 100 mM
bicarbonate buffer, pH 9.4) and incubated at room temperature
for 2 hours. Then the plate wells were blocked with a buffer (3%
skim milk/1% bovine serum albumin/PBS) overnight at 4°C.
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Subsequently, 50 L of diluted cedar pollinosis patients’ sera
(1:20, diluted with blocking buffer) was supplemented into the
well, and incubated overnight at 4°C. Then 50 L of biotinyl-
ated goat antihuman IgE (1:10,000, Biosource International,
Camarillo, CA) was added and incubated for 2 hours at room
temperature, followed by incubation with 50 L alkaline phos-
phatase-conjugated streptavidin (1:10,000, Jackson ImmunoRe-
search Laboratories Inc., West Grove, PA) for 1 hour. For
enzyme reaction, AttoPhos substrate solution (Promega) was
added and incubated at room temperature for 30 minutes.
Then fluorescence intensity of each sample well was analyzed
using a Wallac 1420 ARVOsx Multilabel Counter (Perkin
Elmer Life Sciences, Boston, MA). The cut-off value was
defined as mean ELISA value 3 SD from normal healthy
control sera (n  5).
For competitive ELISA, CPA9-positive Japanese cedar
pollinosis patients’ serum pool (1:10 dilution, n  6) was
preincubated with serial dilutions of competitors [melon extract,
CJP extract as a positive control, and ovalbumin (OVA, pur-
chased from Sigma) as a negative control] at room temperature
for 2 hours. The sera were then applied onto a previously
prepared n-CPA9-coated microtiter plate for testing IgE cross-
reactivity. Subsequent secondary antibody staining and signal
detection was carried out as described above.
RESULTS AND DISCUSSION
Molecular Cloning of a New C. japonica Pollen
Allergen Structurally Belonging to Plant
Subtilisin-Like Serine Protease Family
Our comprehensive 2-D IgE immunoblotting study pro-
vided a compelling evidence for the presence of 31 unidentified
major allergen spots that showed a higher IgE-binding frequency
than that of Cry j 2 (40%).6 Among these spots, we focused on
the spot No. 9 (50% IgE-binding frequency), because its internal
amino acid sequence (GHGTHTSSTAA, determined by
TOF-MS and tandemMS/MS analyses) was highly homologous
to peptidases. Using this sequence information, we cloned full-
length cDNA encoding CPA9 by 5- and 3-RACE-PCR. Nu-
cleotide sequencing and BLAST analyses revealed that cpa9
cDNA composed of 2562 nucleotides encoding 757 amino
acids, which was homologous to subtilisin-like serine protease
family (data not shown). Its calculated molecular weight and
isoelectric point were 80148.79 Da and 6.22, respectively. The
CPA9 sequence contained the catalytic triad (D, H, S) respon-
sible for the proteolytic activity of subtilisin-like serine pro-
teases.25 The phylogenetic analysis of CPA9 polypeptide with
other plant serine proteases using ClastalW software showed
that CPA9 was a member of clan SB (data not shown). The
characteristic amino acid sequences around the catalytic triad
also strongly suggested that CPA9 was classified into a member
of subtilisin-like peptidase (subfamily S8A), as designated by
the MEROPS peptidase database.26 Intriguingly, we also found
that this family contained the melon major allergen Cuc m 1,27
which was highly homologous to CPA9 (40.1% identity and
55.1% similarity).
Preparation of r-CPA9 and Specific Antisera
We next tried to produce r-CPA9 using E. coli cold
shock expression system. SDS-PAGE and anti-His immuno-
blotting analyses revealed a successful soluble expression of
145 kDa r-CPA9-TF fusion protein. We purified this fusion
protein using His-Trap chelate affinity chromatography, and
nonfusion r-CPA9 (seen as a single band protein under silver
staining of a SDS-PAGE gel) was prepared by thrombin
digestion and further purification by nonreducing SDS-PAGE
and gel extraction procedures (data not shown). We also
prepared murine CPA9-specific antisera upon immunization
with the purified r-CPA9.
Purification of n-CPA9
For further immunochemical characterization of CPA9,
we next sought to obtain n-CPA9 from C. japonica pollen
extract. Two successive chromatographic steps on a HiTrap
Butyl HP hydrophobic interaction column and a Mono Q
anion exchange column yielded a single 90 kDa protein as
seen under reducing SDS-PAGE analysis (data not shown).
Immunoblotting also indicated that the obtained 90 kDa
protein was recognized by anti-CPA9 polyclonal antibody.
Furthermore, TOF-MS/MS analysis demonstrated that 2 in-
ternal amino acid sequences of the 90 kDa antigen were
completely coincided with those deduced from cpa9 cDNA.
Taken together, we concluded that the purified 90 kDa mol-
ecule was n-CPA9.
Potent IgE-Binding Capacity of n-CPA9 and Its
Cross-Reactivity with Melon Extract
To examine IgE-binding frequency of n-CPA9, we next
performed ELISA using sera from 26 Japanese cedar polli-
nosis patients (RAST score 2) and 5 healthy donors as a
control. We found that n-CPA9 showed 88.5% IgE binding
frequency (23/26), which was higher than that observed
against major allergen Cry j 1 (65.4%, 17/26, data not
shown). This suggests that CPA9 is an additional major
Japanese cedar pollen allergen.
FIGURE 1. IgE cross-reactivity of n-CPA9 with melon ex-
tract. Competitive ELISA was performed by preincubation of
a pool of CPA9-positive Japanese cedar pollinosis patient sera
(n  6) with serial concentrations of melon extract, CJP ex-
tract (positive control), or OVA (negative control).
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Because CPA9 polypeptide was highly homologous to
the melon subtilisin-like endopeptidase allergen Cuc m 1,27
we next tested whether r-CPA9 showed IgE cross-reactivity
with melon extract. As shown in Figure 1, competitive
ELISA revealed that the melon extract inhibited the binding
of IgE in pooled patients’ sera to immobilized n-CPA9 in a
dose-dependent manner; 45% inhibition of IgE-binding was
observed upon supplementation of 1 g/ml melon extract,
and preincubation with 10 g/ml extract completely inhibited
IgE-binding. We also found that C. japonica pollen extract
(CJP extract, positive control) showed a nice inhibitory ac-
tion, whereas no competition was observed upon incubation
with OVA (negative control). These results raise a possibility
that this subtilisin-like serine protease might be a new class of
plant cross-reactive allergen, although actual IgE-cross-reac-
tivity to Cuc m 1 and to other subtilisin-like allergens needs
to be confirmed in future studies.
CONCLUSIONS
In summary, we identified a novel class of Japanese
cedar pollen allergen (CPA9) homologous to the plant sub-
tilisin-like serine proteases. Its higher IgE-binding frequency
than that of the major allergen Cry j 1 suggests that this
molecule should be an additional important allergen in Jap-
anese cedar pollinosis, although further analyses are needed
to better characterize its allergenicity and proallergic potency.
We believe that CPA9 would be applicable for the develop-
ment of component-resolved diagnosis and specific immuno-
therapy of Japanese cedar pollinosis. Furthermore, this mol-
ecule offers a good model to assess a possible role of serine
protease activity in the pathogenesis of cedar pollinosis.
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